Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Bukwang Pharmaceutical (003000 KS)
Watchlist
39
Analysis
Health Care
•
South Korea
Bukwang Pharmaceutical Co., Ltd. produces oral hygienic, and pharmaceutical products. The Company's products include over-the-counter drugs, toothpastes, and toothbrushes.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
KakaoBank
•
27 Mar 2022 11:39
KOSPI 200 Index Rebalancing: Constituents Subject to Float Rate Increase
This post investigates those among the KOSPI 200 constituents, which will face an increase in the float rate, thereby attracting a meaningful level...
Sanghyun Park
Follow
624 Views
Share
bullish
•
Hana Tour Service
•
10 Mar 2022 12:37
KOSPI 200 Rebalancing Screening: Few Noticeable Changes in the Race
This post offers the latest update on the KOSPI 200 rebalancing screening. There are a few noticeable changes: Hana Tour (addition) and Bukwang...
Sanghyun Park
Follow
520 Views
Share
bearish
•
Bukwang Pharmaceutical
•
15 Feb 2022 20:16
Initial Thoughts on the KOSPI200 Rebalance in June 2022
We discuss the potential additions and deletions in the upcoming June 2022 KOSPI200 rebalance. Top 10 potential inclusions are down on average 4.4%...
Douglas Kim
Follow
541 Views
Share
bullish
•
Kakaopay
•
09 Dec 2021 16:05
KOSPI 200 New Entrants: KRX-Concluded Float Rates & Rebalancing Trading Pattern Today
Kakao Pay eventually received a 35% float rate, meaning that KRX has included all of Alipay's non-locked stake in the float.
Sanghyun Park
Follow
549 Views
Share
bullish
•
HD Hyundai Heavy Industries
•
01 Nov 2021 08:01
KOSPI200 Index Rebalance Preview: Review Period Complete & Trades Performing Well
The review period for the KOSPI200 Dec rebalance is complete and we see 6 potential adds and 8 potential deletes. Most are high probability changes...
Brian Freitas
Follow
580 Views
Share
First
Previous
4
5
6
7
8
Next
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x